51.0 MB (669.8 KB compressed)
5173 x 3449 pixels
43.7 x 29.2 cm ⏐ 17.2 x 11.5 in (300dpi)
DR P. MARAZZI / SCIENCE PHOTO LIBRARY DR P. MARAZZI / SCIENCE PHOTO LIBRARY
Editorial use only.
Tivozanib kidney cancer drug. Close-up of a tub containing capsules of the kidney cancer drug tivozanib, marketed under the name Fotivda. Tivozanib is an oral VEGF receptor tyrosine kinase inhibitor used for the treatment of first line (treatment naive) patients with renal cell carcinoma.
Model release not required. Property release not required.